Shorted
Healius logo
HLS
Health Care Equipment & Services

Healius

Short interest
2.36%
−5.41 pp 30d
as of 12 Oct 2026
Reported shorts
17.2M
Shares on issue
726.179M

Healius (HLS) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Positive
9 Oct

Is Healius (ASX:HLS) Cleaner After the Agilex Sale?

Highlights The pathology operator agreed to offload its clinical-trial laboratory business and expects to be in net cash. Shares jumped on the news, and short positions in the stock eased as the market reassessed the balance sheet. The remaining pathology and imaging business still faces thin margins and a year of restructuring. Healius (ASX:HLS), the diagnostics group best known for pathology collection centres and medical imaging, agreed to offload its Agilex Biolabs clinical-trial laborato...

Continue reading
Kalkine
Neutral
8 Oct

Can the Agilex Sale Reset Healius's Story (ASX:HLS)?

Highlights Healius agreed to dispose of Agilex Biolabs to a unit of Novotech. Proceeds are expected to leave the pathology group with net cash after completion. Regulatory approvals and pathology volumes are the next tests. Healius (ASX:HLS) has signed a binding agreement to dispose of its Agilex Biolabs arm to a unit of Novotech, a move that sharpens the pathology group's focus and points to a cleaner balance sheet. The Australian market ended Wednesday a touch lower, with healthcare small c...

Continue reading
Kalkine
Neutral
5 Oct

Mitsubishi UFJ Financial Group Declares Initial Substantial Holding in Healius Limited

Healius Limited (ASX:HLS) has been identified as the subject company in an initial substantial holder notice, with Mitsubishi UFJ Financial Group reporting a relevant interest of 37,438,909 fully paid ordinary shares, equating to 5.16% voting power as of 1 October 2026. Key Highlights Mitsubishi UFJ Financial Group became a substantial shareholder in Healius Limited on 1 October 2026. The disclosed relevant interest totals 37,438,909 fully paid ordinary shares, representing 5.16% of voting ri...

Continue reading
Kalkine
Neutral
23 Sept

What could Healius (ASX:HLS) annual report reveal?

Highlights Healius has a fresh corporate disclosure centred on its annual report. The update places the healthcare services company within the broader Value Stocks category without extending the announcement beyond its confirmed content. The annual report creates a formal information checkpoint, while any further developments depend on subsequent company communication. A fresh annual report can give an ASX-listed company renewed attention because it brings a broad collection of corporate...

Continue reading
Kalkine
Neutral
22 Sept

What Does Healius’ (ASX:HLS) Governance Update Show?

Highlights Healius has lodged its updated corporate governance statement and accompanying Appendix 4G with the ASX. The disclosure outlines governance arrangements covering board responsibilities, appointments and company secretary accountability. Healius operates in Australias healthcare sector, providing pathology and diagnostic services. Healius Limited (ASX:HLS) has provided the Australian Securities Exchange with an updated corporate governance statement, giving the market a refreshed vie...

Continue reading
Kalkine
Negative
20 Aug

Healius (ASX:HLS) Faces Tough Test After Goodwill Blow: Value Opportunity or Warning Sign?

Highlights Healius records a major goodwill impairment, putting renewed focus on balance sheet strength. Operational improvements support earnings recovery, but debt and restructuring costs remain under scrutiny. The healthcare group's turnaround story now depends on sustainable margin expansion rather than revenue growth. Australia's australian stock market continues to present contrasting stories, with some companies delivering stronger operational performance while others grapple with...

Continue reading